pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
NS-050
Duchenne Muscular Dystrophy
NS Pharma Inc
0 catalysts
Preclinical
NS-051
Duchenne Muscular Dystrophy
NS Pharma Inc
0 catalysts
Phase 2
NS-229
Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)
Nippon Shinyaku Co Ltd
0 catalysts
Phase 2
NT-101
Wet (Neovascular / Exudative) Macular Degeneration
← prev
page 114 of 231
next →
131
Pain89
Neurology1
NexThera Co Ltd
0 catalysts
Preclinical
NT-102
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Neuroene Therapeutics LLC
0 catalysts
Phase 2
NT-219
Metastatic Colorectal Cancer
$PPBTPURPLE BIOTECH LTD.
0 catalysts
Phase 2
NTCDM-3
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Destiny Pharma Ltd
0 catalysts
Preclinical
NTG-101
Degenerative Disc Disease
Notogen Inc
0 catalysts
Preclinical
NTM-004
Pain
Neumentum Inc
0 catalysts
Preclinical
NTM-005
Pain
Neumentum Inc
0 catalysts
Phase 2
NTM-006
Post-Operative Pain
Neumentum Inc
0 catalysts
Phase 3
NTO-1151
Triapine
Cervical Cancer
Ribonucleotide reductase
Resilience Government Services Inc
0 catalysts
Phase 1
NTP-42
Pulmonary Arterial Hypertension
ATXA Therapeutics Ltd
0 catalysts
Phase 1
NTS-1104
Acute Ischemic Stroke
NeuroTrauma Sciences LLC
0 catalysts
Phase 3
NTX-001
Peripheral Nerve Injury
Neuraptive Therapeutics Inc
0 catalysts
Phase 2
NTX-1472
Social Anxiety Disorder (SAD/Social Phobia)
Newleos Therapeutics Inc
0 catalysts
Phase 2
NTX-301
Chronic Myelomonocytic Leukemia (CMML)
Pinotbio Inc
0 catalysts
Preclinical
NTY-184
Major Depressive Disorder
Neuromity Therapeutics Inc
0 catalysts
Preclinical
NU-001
Ovarian Cancer
NUAgo Therapeutics Inc
0 catalysts
Preclinical
NU-01
Heavy Metal Poisoning
Medesis Pharma SA
0 catalysts
phase_0
NU-0129
Gliosarcoma
Northwestern University
0 catalysts
Preclinical
NU-02
Heavy Metal Poisoning
Medesis Pharma SA
0 catalysts
Preclinical
NV-101
Ewing Sarcoma
Oncology Pharma Inc
0 catalysts
Preclinical
NV-354
Subacute Necrotizing Encephalomyelopathy (Leigh Disease)
Abliva AB
0 catalysts
Preclinical
NV-360
Herpes Zoster (Shingles)
$NNVCNANOVIRICIDES, INC.
0 catalysts
Phase 3
NVD-003
Pseudarthrosis (Nonunion of Fracture/Pseudoarthrosis)
Novadip Biosciences SA
0 catalysts
Phase 2
NVG-291
Chronic Spinal Cord Injury
$NGENNERVGEN PHARMA CORP.
0 catalysts
Preclinical
NVK-006
Unspecified Infectious Diseases
Nevakar Injectables Inc
0 catalysts
Phase 1
NVK-029
Presbyopia
Vyluma Inc
0 catalysts
Phase 1
NVK-031
Unspecified Ophthalmological Disorders
Vyluma Inc
0 catalysts